Haleon PLC

H6D0

Company Profile

  • Business description

    Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

  • Contact

    The Heights
    Building 5, First Floor
    Surrey
    WeybridgeKT13 0NY
    GBR

    T: +44 1932959500

    E: [email protected]

    https://www.haleon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    24,622

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,828.7873.47-0.93%
DAX 4024,265.12191.69-0.78%
Dow JONES (US)44,416.92233.72-0.52%
FTSE 1008,940.9134.75-0.39%
HKSE24,139.57111.200.46%
NASDAQ20,625.934.74-0.02%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,262.0518.41-0.29%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers